PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Percorso Life Sciences (PLS) announces an agreement to represent Generation Biotech (GB) to commercialize its SNPSeqTM product portfolio and provide strategic business development. PLS specializes in providing solutions to the business challenges of life science organizations seeking to enter or strengthen their commercial focus in the marketplace. Percorso partners with its clients to develop and execute innovative business and channel strategies calculated to maximize value within the client organization. Generation Biotech is a privately held biotechnology company whose proprietary magnetic bead-based haplotype- and region-specific extraction (HSE/RSE) allows the sequence-specific isolation of large DNA segments.
